Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Hepatology ; 72(6): 2149-2164, 2020 12.
Article de Anglais | MEDLINE | ID: mdl-32170749

RÉSUMÉ

BACKGROUND AND AIMS: Liver regeneration requires the organized and sequential activation of events that lead to restoration of hepatic mass. During this process, other vital liver functions need to be preserved, such as maintenance of blood glucose homeostasis, balancing the degradation of hepatic glycogen stores, and gluconeogenesis (GNG). Under metabolic stress, alanine is the main hepatic gluconeogenic substrate, and its availability is the rate-limiting step in this pathway. Na+ -coupled neutral amino acid transporters (SNATs) 2 and 4 are believed to facilitate hepatic alanine uptake. In previous studies, we demonstrated that a member of the Ca2+ -dependent phospholipid binding annexins, Annexin A6 (AnxA6), regulates membrane trafficking along endo- and exocytic pathways. Yet, although AnxA6 is abundantly expressed in the liver, its function in hepatic physiology remains unknown. In this study, we investigated the potential contribution of AnxA6 in liver regeneration. APPROACH AND RESULTS: Utilizing AnxA6 knockout mice (AnxA6-/- ), we challenged liver function after partial hepatectomy (PHx), inducing acute proliferative and metabolic stress. Biochemical and immunofluorescent approaches were used to dissect AnxA6-/- mice liver proliferation and energetic metabolism. Most strikingly, AnxA6-/- mice exhibited low survival after PHx. This was associated with an irreversible and progressive drop of blood glucose levels. Whereas exogenous glucose administration or restoration of hepatic AnxA6 expression rescued AnxA6-/- mice survival after PHx, the sustained hypoglycemia in partially hepatectomized AnxA6-/- mice was the consequence of an impaired alanine-dependent GNG in AnxA6-/- hepatocytes. Mechanistically, cytoplasmic SNAT4 failed to recycle to the sinusoidal plasma membrane of AnxA6-/- hepatocytes 48 hours after PHx, impairing alanine uptake and, consequently, glucose production. CONCLUSIONS: We conclude that the lack of AnxA6 compromises alanine-dependent GNG and liver regeneration in mice.


Sujet(s)
Annexine A6/métabolisme , Néoglucogenèse/physiologie , Régénération hépatique/physiologie , Animaux , Annexine A6/génétique , Membrane cellulaire/métabolisme , Modèles animaux de maladie humaine , Glucose/métabolisme , Glycolyse/physiologie , Hépatectomie , Hépatocytes/métabolisme , Humains , Foie/cytologie , Foie/métabolisme , Foie/chirurgie , Mâle , Souris , Souris knockout
2.
Mol Immunol ; 82: 19-33, 2017 02.
Article de Anglais | MEDLINE | ID: mdl-28006656

RÉSUMÉ

During immune cell activation, serine-derived lipids such as phosphatidylserine and sphingolipids contribute to the formation of protein signaling complexes within the plasma membrane. Altering lipid composition in the cell membrane can subsequently affect immune cell function and the development of autoimmune disease. Serine incorporator 1 (SERINC1) is a putative carrier protein that facilitates synthesis of serine-derived lipids. To determine if SERINC1 has a role in immune cell function and the development of autoimmunity, we characterized a mouse strain in which a retroviral insertion abolishes expression of the Serinc1 transcript. Expression analyses indicated that the Serinc1 transcript is readily detectable and expressed at relatively high levels in wildtype macrophages and lymphocytes. The ablation of Serinc1 expression in these immune cells, however, did not significantly alter serine-derived lipid composition or affect macrophage function and lymphocyte proliferation. Analyses of Serinc1-deficient mice also indicated that systemic ablation of Serinc1 expression did not affect viability, fertility or autoimmune disease susceptibility. These results suggest that Serinc1 is dispensable for certain immune cell functions and does not contribute to previously reported links between lipid composition in immune cells and autoimmunity.


Sujet(s)
Maladies auto-immunes/immunologie , Prédisposition aux maladies/immunologie , Activation des lymphocytes/immunologie , Activation des macrophages/immunologie , Protéines membranaires/immunologie , Animaux , Séparation cellulaire , Diabète expérimental/immunologie , Modèles animaux de maladie humaine , Cytométrie en flux , Métabolisme lipidique/immunologie , Macrophages/immunologie , Souris , Souris knockout , Réaction de polymérisation en chaîne , Sérine/métabolisme
3.
J Immunol ; 196(10): 3993-4002, 2016 05 15.
Article de Anglais | MEDLINE | ID: mdl-27183636

RÉSUMÉ

Although it is recognized that lipids and membrane organization in T cells affect signaling and T cell activation, to what extent dietary lipids alter T cell responsiveness in the absence of obesity and inflammation is not known. In this study, we fed low-density lipoprotein receptor knockout mice a Western high-fat diet for 1 or 9 wk and examined T cell responses in vivo along with T cell lipid composition, membrane order, and activation ex vivo. Our data showed that high levels of circulating lipids for a prolonged period elevated CD4(+) and CD8(+) T cell proliferation and resulted in an increased proportion of CD4(+) central-memory T cells within the draining lymph nodes following induction of contact hypersensitivity. In addition, the 9-wk Western high-fat diet elevated the total phospholipid content and monounsaturated fatty acid level, but decreased saturated phosphatidylcholine and sphingomyelin within the T cells. The altered lipid composition in the circulation, and of T cells, was also reflected by enhanced membrane order at the activation site of ex vivo activated T cells that corresponded to increased IL-2 mRNA levels. In conclusion, dietary lipids can modulate T cell lipid composition and responses in lipoprotein receptor knockout mice even in the absence of excess weight gain and a proinflammatory environment.


Sujet(s)
Lymphocytes T CD4+/immunologie , Lymphocytes T CD8+/immunologie , Eczéma de contact/immunologie , Métabolisme lipidique , Animaux , Membrane cellulaire/composition chimique , Membrane cellulaire/métabolisme , Prolifération cellulaire , Cellules cultivées , Alimentation riche en graisse , Acides gras monoinsaturés/métabolisme , Mémoire immunologique , Interleukine-2/génétique , Interleukine-2/métabolisme , Activation des lymphocytes , Souris , Souris de lignée C57BL , Souris knockout , Récepteurs aux lipoprotéines LDL/génétique , Transduction du signal , Sphingomyéline/métabolisme
4.
Immunol Cell Biol ; 94(6): 543-53, 2016 07.
Article de Anglais | MEDLINE | ID: mdl-26853809

RÉSUMÉ

Annexin A6 (AnxA6) has been implicated in cell signalling by contributing to the organisation of the plasma membrane. Here we examined whether AnxA6 regulates signalling and proliferation in T cells. We used a contact hypersensitivity model to immune challenge wild-type (WT) and AnxA6(-/-) mice and found that the in vivo proliferation of CD4(+) T cells, but not CD8(+) T cells, was impaired in AnxA6(-/-) relative to WT mice. However, T-cell migration and signalling through the T-cell receptor ex vivo was similar between T cells isolated from AnxA6(-/-) and WT mice. In contrast, interleukin-2 (IL-2) signalling was reduced in AnxA6(-/-) compared with WT T cells. Further, AnxA6-deficient T cells had reduced membrane order and cholesterol levels. Taken together, our data suggest that AnxA6 regulates IL-2 homeostasis and sensitivity in T cells by sustaining a lipid raft-like membrane environment.


Sujet(s)
Annexine A6/métabolisme , Interleukine-2/métabolisme , Lymphocytes T/cytologie , Lymphocytes T/métabolisme , Animaux , Annexine A6/déficit , Membrane cellulaire/métabolisme , Mouvement cellulaire , Prolifération cellulaire , Cholestérol/métabolisme , Eczéma de contact/immunologie , Eczéma de contact/anatomopathologie , Interleukine-2/biosynthèse , Activation des lymphocytes , Souris de lignée C57BL , Phosphorylation , Récepteurs aux antigènes des cellules T/métabolisme , Récepteurs à l'interleukine-2/métabolisme , Facteur de transcription STAT-5/métabolisme , Transduction du signal
5.
FASEB J ; 26(3): 1272-9, 2012 Mar.
Article de Anglais | MEDLINE | ID: mdl-22106367

RÉSUMÉ

Alum adjuvants have been in continuous clinical use for more than 80 yr. While the prevailing theory has been that depot formation and the associated slow release of antigen and/or inflammation are responsible for alum enhancement of antigen presentation and subsequent T- and B-cell responses, this has never been formally proven. To examine antigen persistence, we used the chimeric fluorescent protein EαGFP, which allows assessment of antigen presentation in situ, using the Y-Ae antibody. We demonstrate that alum and/or CpG adjuvants induced similar uptake of antigen, and in all cases, GFP signal did not persist beyond 24 h in draining lymph node antigen-presenting cells. Antigen presentation was first detectable on B cells within 6-12 h of antigen administration, followed by conventional dendritic cells (DCs) at 12-24 h, then finally plasmacytoid DCs at 48 h or later. Again, alum and/or CpG adjuvants did not have an effect on the magnitude or sequence of this response; furthermore, they induced similar antigen-specific T-cell activation in vivo. Notably, removal of the injection site and associated alum depot, as early as 2 h after administration, had no appreciable effect on antigen-specific T- and B-cell responses. This study clearly rules out a role for depot formation in alum adjuvant activity.


Sujet(s)
Alun/pharmacologie , Présentation d'antigène/effets des médicaments et des substances chimiques , Cellules présentatrices d'antigène/effets des médicaments et des substances chimiques , Antigènes/immunologie , Adjuvants immunologiques/pharmacologie , Animaux , Présentation d'antigène/immunologie , Cellules présentatrices d'antigène/immunologie , Cellules présentatrices d'antigène/métabolisme , Antigènes/administration et posologie , Antigènes/métabolisme , Lymphocytes B/effets des médicaments et des substances chimiques , Lymphocytes B/immunologie , Lymphocytes B/métabolisme , Cellules dendritiques/effets des médicaments et des substances chimiques , Cellules dendritiques/immunologie , Cellules dendritiques/métabolisme , Femelle , Cytométrie en flux , Noeuds lymphatiques/effets des médicaments et des substances chimiques , Noeuds lymphatiques/immunologie , Noeuds lymphatiques/métabolisme , Activation des lymphocytes/effets des médicaments et des substances chimiques , Activation des lymphocytes/immunologie , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris transgéniques , Oligodésoxyribonucléotides/pharmacologie , Ovalbumine/administration et posologie , Ovalbumine/immunologie , Ovalbumine/pharmacocinétique , Lymphocytes T/effets des médicaments et des substances chimiques , Lymphocytes T/immunologie , Lymphocytes T/métabolisme , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...